Adicet Bio's (ACET) Outperform Rating Reiterated at Wedbush

Wedbush reiterated their outperform rating on shares of Adicet Bio (NASDAQ:ACET – Free Report) in a report issued on Tuesday, Benzinga reports. Wedbush currently has a $5.00 price target on the stock. A number of other research firms also recently issued reports on ACET. HC Wainwright reiterated a buy rating and set a $10.00 price […]

Related Keywords

Adicet Bio ,Adicet Bio Inc ,Exchange Traded Concepts ,Acadian Asset Management ,Canaccord Genuity Group ,Panagora Asset Management Inc ,York Mellon Corp ,Acuitas Investments ,Free Report ,Genuity Group ,Get Free Report ,Asset Management ,New York Mellon Corp ,Traded Concepts ,Panagora Asset Management ,Adicet Bio Daily ,